9,317
Total Claims
$507K
Drug Cost
851
Beneficiaries
$596
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-61%
Cost per patient vs peers
$596 vs $1,524 avg
-41%
Brand preference vs peers
8.0% vs 13.7% avg
Brand vs Generic
92% generic
Brand: 743 claims · $426K
Generic: 8,562 claims · $81K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 284 | $183K |
| Dapagliflozin Propanediol | 102 | $75K |
| Rivaroxaban | 111 | $72K |
| Sacubitril/Valsartan | 52 | $36K |
| Ticagrelor | 45 | $25K |
| Losartan Potassium | 1,192 | $13K |
| Metoprolol Succinate | 920 | $10K |
| Evolocumab | 12 | $8,489 |
| Rosuvastatin Calcium | 817 | $6,404 |
| Atorvastatin Calcium | 725 | $6,071 |
| Candesartan/Hydrochlorothiazid | 26 | $4,603 |
| Spironolactone | 480 | $4,149 |
| Amlodipine Besylate | 1,090 | $3,985 |
| Hydrochlorothiazide | 655 | $2,711 |
| Terazosin Hcl | 280 | $2,660 |
Prescribing Profile
52
Unique Drugs
$366K
Patient Profile
75
Avg Age
57%
Female
2.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data